Table 1

Demographic and baseline disease characteristics of subjects in the Bosentan Use in Interstitial Lung Disease-1 (BUILD-1) study

VariableN=158
Age65 (9)
BMI29 (4)
Gender (M/F)73/27
Smoking status (%)
 Non/current98/2
Race (%)
 Caucasian92
 Black2
 Asian1
 Hispanic4
 Other1
Baseline FVC (l)2.64 (0.73)
Baseline FVC (% predicted)61.0 (12.2)
Baseline Tlco (% predicted)41.0 (10.1)
6MWD (m)373 (81)
BDI total6.8 (2.1)
  • Data are presented as mean (SD) or percentages.

  • BDI, baseline dyspnoea index; BMI, body mass index; FVC, forced vital capacity; 6MWD, 6-minute walking distance; Tlco, transfer factor of the lung for carbon monoxide.